These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 1430813

  • 1. [Ocular prognosis in Behçet's disease].
    Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong Du, Girard B, Rousselie F, Godeau P.
    J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
    [Abstract] [Full Text] [Related]

  • 2. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M.
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [Abstract] [Full Text] [Related]

  • 3. Ocular involvement in Behçet's disease.
    Peplinski LS.
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [Abstract] [Full Text] [Related]

  • 4. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
    Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I.
    Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
    [Abstract] [Full Text] [Related]

  • 5. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S, Graziani G, Marcolongo R.
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [Abstract] [Full Text] [Related]

  • 6. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M, Amer R, Mukamel M, Snir M, Jaouni T, Friling R.
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [Abstract] [Full Text] [Related]

  • 7. [Ocular manifestations of Behçet's disease].
    Cassoux N, Fardeau C, Lehoang P.
    Ann Med Interne (Paris); 1999 Nov; 150(7):529-34. PubMed ID: 10637668
    [Abstract] [Full Text] [Related]

  • 8. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS.
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].
    Bonnet M.
    J Fr Ophtalmol; 1981 Sep; 4(6-7):455-64. PubMed ID: 7299062
    [Abstract] [Full Text] [Related]

  • 10. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
    Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K.
    Trans Am Ophthalmol Soc; 1979 Sep; 77():225-79. PubMed ID: 397657
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic factors of ocular involvement in Behçet's disease].
    Belkhadir K, Boutimzine N, Laghmari M, Amazouzi A, Tachfouti S, Cherkaoui O.
    J Fr Ophtalmol; 2019 Jun; 42(6):612-617. PubMed ID: 31088739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pars plana vitrectomy for ocular complications of Behçet's disease.
    Sullu Y, Alotaiby H, Beden U, Erkan D.
    Ophthalmic Surg Lasers Imaging; 2005 Jun; 36(4):292-7. PubMed ID: 16156145
    [Abstract] [Full Text] [Related]

  • 14. [Intravenous corticosteroid megadose treatment in ocular Behçet disease].
    Postelmans L, Verougstraete C, Libert J, Efira A, Caspers-Velu L.
    Bull Soc Belge Ophtalmol; 1996 Jun; 262():95-103. PubMed ID: 9376926
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH, Naffati H, Khanfir M, Ghannouchi M, Ben Ghorbel I, Lamloum M, El Matri L, Hamzaoui K, Jeddi A, Miled M, Fki M.
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
    Jpn J Ophthalmol; 2007 Jun; 51(3):191-6. PubMed ID: 17554481
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L, Gini G, Lenzetti I, Cantini F.
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [Abstract] [Full Text] [Related]

  • 20. Comparison of patients with Behçet's disease in the 1980s and 1990s.
    Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M.
    Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.